2024-515786-34-02招募中1 期
A Positron Emission Tomography (PET) study to examine the properties of a novel radioligand's suitability for imaging mutant huntingtin
CHDI Foundation Inc.1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2024年12月17日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 27
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Prof Wim Vandenberghe
Scientific
CHDI Foundation Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A positron emission tomography (PET) study to assess where the radiotracer [11C]AZ14132516 goes in the body following administration to healthy participantsCrohn's disease2022-502843-36-00AstraZeneca AB, AstraZeneca AB9
已完成
不适用
Positron emission tomography (PET) measurement of the displaceability of [11C]FLB 457 from extra-striatal dopamine D2 receptors in maISRCTN23418225Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)16
撤回
1 期
An imaging study of 64Cu-SARTATE using positron emission tomography in paediatric patients with high-risk neuroblastoma.ACTRN12617001259336Clarity Pharmaceuticals LTD10
招募中
不适用
Positron emission computed tomography (PET) with L-[11C] methioninemalignant tumorJPRN-UMIN000010237Yamaguchi University School of Medicine300
尚未招募
不适用
Positron Emission Tomography (PET) imaging of neurodegenerative biomarkers in people ‘at risk’ for dementiaSubjective memory complaintsmild cognitive impairmentNeurological - DementiasNeurological - Neurodegenerative diseasesDementiaACTRN12622000274774The University of Sydney82